Pharmacovigilance Market Is Growing at a CAGR of 12.9% from 2013 to 2019. by Transparency Market Research.
A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge in number of acute and chronic diseases has consequently led to a rise in number of drug consumption, which has also elicited a growth in the number of adverse drug events and drug toxicity cases.
View full press release